Increased Th17 cells are accompanied by FoxP3+ Treg cell accumulation and correlated with psoriasis disease severity

Clinical Immunology

Volumn 135, Issue 1, 2010, Pages 108-117

  Zhang, Li ^a   Yang, Xue Qin ^b   Cheng, Juan ^c   Hui, Rang Song ^c   Gao, Tian Wen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

FoxP3; IL 17; Psoriasis; T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; FOXP3+ REGULATORY T CELL; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REGULATORY T LYMPHOCYTE; TH17 CELL;

CELL GROWTH PROCESSES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; MALE; PSORIASIS; SKIN; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY;

EID: 77649235565     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.11.008     Document Type: Article

References (49)

1. Caproni M., Antiga E., Melani L., Volpi W., Del Bianco E., and Fabbri P. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. J. Clin. Immunol. 29 (2009) 210-214
2. Sabat R., Philipp S., Hoflich C., Kreutzer S., Wallace E., Asadullah K., Volk H.D., Sterry W., and Wolk K. Immunopathogenesis of psoriasis. Exp. Dermatol. 16 (2007) 779-798
3. van Beelen A.J., Teunissen M.B., Kapsenberg M.L., and de Jong E.C. Interleukin-17 in inflammatory skin disorders. Curr. Opin. Allergy Clin. Immunol. 7 (2007) 374-381
4. Zaba L.C., Cardinale I., Gilleaudeau P., Sullivan-Whalen M., Suarez-Farinas M., Fuentes-Duculan J., Novitskaya I., Khatcherian A., Bluth M.J., Lowes M.A., and Krueger J.G. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 204 (2007) 3183-3194
5. Boniface K., Guignouard E., Pedretti N., Garcia M., Delwail A., Bernard F.X., Nau F., Guillet G., Dagregorio G., Yssel H., Lecron J.C., and Morel F. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin. Exp. Immunol. 150 (2007) 407-415
6. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., and Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007) 648-651
7. Wolk K., Witte E., Wallace E., Docke W.D., Kunz S., Asadullah K., Volk H.D., Sterry W., and Sabat R. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36 (2006) 1309-1323
8. Piskin G., Sylva-Steenland R.M., Bos J.D., and Teunissen M.B. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J. Immunol. 176 (2006) 1908-1915
9. Li J., Li D., and Tan Z. The expression of interleukin-17, interferon-gamma, and macrophage inflammatory protein-3 alpha mRNA in patients with psoriasis vulgaris. J. Huazhong Univ. Sci. Technolog. Med. Sci. 24 (2004) 294-296
10. Lee E., Trepicchio W.L., Oestreicher J.L., Pittman D., Wang F., Chamian F., Dhodapkar M., and Krueger J.G. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 199 (2004) 125-130
11. Lowes M.A., Kikuchi T., Fuentes-Duculan J., Cardinale I., Zaba L.C., Haider A.S., Bowman E.P., and Krueger J.G. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128 (2008) 1207-1211
12. Zaba L.C., Fuentes-Duculan J., Eungdamrong N.J., Abello M.V., Novitskaya I., Pierson K.C., Gonzalez J., Krueger J.G., and Lowes M.A. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J. Invest. Dermatol. 129 (2009) 79-88
13. + Treg cells in psoriasis vulgaris. J. Dermatol. Sci. 51 (2008) 200-203
14. + T cells in normal skin and inflammatory dermatoses. J. Histochem. Cytochem. 55 (2007) 891-898
15. + regulatory T cells in Psoriasis. Dermatology 213 (2006) 111-117
16. high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 174 (2005) 164-173
17. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 (2005) 1123-1132
18. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., and Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6 (2005) 1133-1141
19. + T helper cells. Cell 126 (2006) 1121-1133
20. Tesmer L.A., Lundy S.K., Sarkar S., and Fox D.A. Th17 cells in human disease. Immunol. Rev. 223 (2008) 87-113
21. Hohl T.M., Rivera A., and Pamer E.G. Immunity to fungi. Curr. Opin. Immunol. 18 (2006) 465-472
22. Korn T., Bettelli E., Oukka M., and Kuchroo V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27 (2009) 485-517
23. Mills K.H. Induction, function and regulation of IL-17-producing T cells. Eur. J. Immunol. 38 (2008) 2636-2649
24. Teunissen M.B., Koomen C.W., de Waal Malefyt R., Wierenga E.A., and Bos J.D. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 111 (1998) 645-649
25. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., and Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193 (2001) 1285-1294
26. Levings M.K., Sangregorio R., and Roncarolo M.G. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193 (2001) 1295-1302
27. Dieckmann D., Plottner H., Berchtold S., Berger T., and Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 193 (2001) 1303-1310
28. high regulatory cells in human peripheral blood. J. Immunol. 167 (2001) 1245-1253
29. + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177 (2006) 739-747
30. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243 (2000) 147-154
31. Pala P., Hussell T., and Openshaw P.J. Flow cytometric measurement of intracellular cytokines. J. Immunol. Methods 243 (2000) 107-124
32. Arican O., Aral M., Sasmaz S., and Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediat. Inflamm. 2005 (2005) 273-279
33. Ichiyama K., Yoshida H., Wakabayashi Y., Chinen T., Saeki K., Nakaya M., Takaesu G., Hori S., Yoshimura A., and Kobayashi T. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. J. Biol. Chem. 283 (2008) 17003-17008
34. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., Shen Y., Du J., Rubtsov Y.P., Rudensky A.Y., Ziegler S.F., and Littman D.R. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453 (2008) 236-240
35. Zhang F., Meng G., and Strober W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9 (2008) 1297-1306
36. Huter E.N., Stummvoll G.H., DiPaolo R.J., Glass D.D., and Shevach E.M. Cutting edge: antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease. J. Immunol. 181 (2008) 8209-8213
37. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., Parente E., Fili L., Ferri S., Frosali F., Giudici F., Romagnani P., Parronchi P., Tonelli F., Maggi E., and Romagnani S. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204 (2007) 1849-1861
38. Evans H.G., Suddason T., Jackson I., Taams L.S., and Lord G.M. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 17034-17039
39. Sutton C., Brereton C., Keogh B., Mills K.H., and Lavelle E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203 (2006) 1685-1691
40. Kimura A., Naka T., and Kishimoto T. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 12099-12104
41. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., and Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
42. Jain R., Tartar D.M., Gregg R.K., Divekar R.D., Bell J.J., Lee H.H., Yu P., Ellis J.S., Hoeman C.M., Franklin C.L., and Zaghouani H. Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J. Exp. Med. 205 (2008) 207-218
43. Irmler I.M., Gajda M., and Brauer R. Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J. Immunol. 179 (2007) 6228-6236
44. Cruz A., Khader S.A., Torrado E., Fraga A., Pearl J.E., Pedrosa J., Cooper A.M., and Castro A.G. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 177 (2006) 1416-1420
45. Beriou G., Costantino C.M., Ashley C.W., Yang L., Kuchroo V.K., Baecher-Allan C., and Hafler D.A. IL-17 producing human peripheral regulatory T cells retain suppressive function. Blood 113 (2009) 4240-4249
46. + antigen-specific autoimmune effectors in vitro and in vivo. J. Immunol. 181 (2008) 3137-3147
47. Koenen H.J., Smeets R.L., Vink P.M., van Rijssen E., Boots A.M., and Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112 (2008) 2340-2352
48. Wang Z., Hong J., Sun W., Xu G., Li N., Chen X., Liu A., Xu L., Sun B., and Zhang J.Z. Role of IFN-gamma in induction of Foxp3 and conversion of CD4 CD25 T cells to CD4 Tregs. J. Clin. Invest. 116 (2006) 2434-2441
49. Zhang X.J., Yan K.L., Wang Z.M., Yang S., Zhang G.L., Fan X., Xiao F.L., Gao M., Cui Y., Wang P.G., Sun L.D., Zhang K.Y., Wang B., Wang D.Z., Xu S.J., Huang W., and Liu J.J. Polymorphisms in interleukin-15 gene on chromosome 4q31.2 are associated with psoriasis vulgaris in Chinese population. J. Invest. Dermatol. 127 (2007) 2544-2551